Skip to main content

Table 3 Association of PENK-A with incident CKD (defined as new eGFR < 60 mL/min/1.73m2 plus at least 25% eGFR decline)a

From: Plasma proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort

 

Quartiles of PENK-A

Q1

Q2

Q3

Q4

Per SD higher

P value+

(OR, 95% CI)

(OR, 95% CI)

(OR, 95% CI)

(OR, 95% CI)

(OR, 95% CI)

Range of PENK-A

< 48

48–56

57–70

> 70

  

Number of events/Number at Risk (%)

 BioMedioR

112/909 (12.3)

135/908 (14.9)

172/909 (18.9)

205/908 (22.6)

624/3634 (17.2)

 

 Weighted

340/1760 (19.3)

395/1765 (22.4)

472/1756 (26.8)

516/1759 (29.3)

1723/7040 (24.5)

 

 Model 1*

Reference

1.17 (0.88, 1.53)

1.45 (1.11, 1.88)

1.87 (1.42, 2.45)

1.24 (1.13, 1.37)

< 0.001

 Model 2**

Reference

1.40 (1.05, 1.87)

1.97 (1.49, 2.60)

2.93 (2.18, 3.94)

1.52 (1.35, 1.71)

< 0.001

 Model 3***

Reference

1.12 (0.83, 1.51)

1.32 (0.98, 1.78)

1.43 (1.03, 1.97)

1.15 (1.01, 1.31)

0.03

  1. P for interaction for sex: 0.18
  2. P for interaction for race: 0.44
  3. aWeighted to parent cohort and excluding participants missing PENK-A and baseline CKD
  4. *Adjusted for age, sex, race
  5. **Adjusted for Model 1 plus body mass index, current smoking, coronary artery disease, systolic blood pressure, use of antihypertensive meds, diabetes mellitus
  6. ***Adjusted for Model 2 plus baseline eGFR and uACR
  7. + P value for SD higher of PENK-A